Clinical trial

Proteinopathies Expression in Skin of Neurodegenerative Disorders

NCT06528964

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Immunohistochemistry and immunofluorescence Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Proteinopathies Expression in Skin of Neurodegenerative Disorders

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-12-20

PhaseN/A

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Frontotemporal Dementiaverified · MONDO: frontotemporal dementia

Parkinson Diseaseverified · MONDO: Parkinson disease

Atypical Parkinsonismunresolved

Amyotrophic Lateral Sclerosisverified · MONDO: amyotrophic lateral sclerosis

Normal Pressure Hydrocephalusverified · MONDO: normal pressure hydrocephalus

Interventions

Immunohistochemistry and immunofluorescenceDIAGNOSTIC_TEST

Sponsors & collaborators

Universidad Autonoma de San Luis Potosílead sponsor

Hospital Central "Dr. Ignacio Morones Prieto"collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06528964 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.